Goldberg will serve as an entrepreneur-in-residence, or EIR, through the . In this role, he will work with UofL to connect inventions to industry and startups.

Goldberg brings nearly 30 years of experience as a medical doctor and C-suite executive, previously working for major brands and startups including ExpressScripts and Aetna Inc. Goldberg recently retired as Chief Health Officer of clinical laboratory Quest Diagnostics, where he also supported the enterprise investment fund and new ventures.

“UofL is doing some really interesting and impactful work in developing new diagnostics, treatments and therapies,” Goldberg said. “I’m excited to work with the team and with the university’s researchers to help drive those innovations to market and clinical settings, where they can help patients.”

Goldberg joins a class of EIRs that currently includes seasoned founders Alice Shade (healthcare), Tendai Charasika (software), Bill Dawson (health and biotech) and Chirs Bailey (manufacturing). Shade joined as part of the second round of EIRs in 2020, followed by Charasika in 2021 and Dawson and Bailey in 2023.

The EIR program is led by the Office of Research and Innovation’s UofL New Ventures team, which focuses on launching startups around research-born tech. The EIR program is in partnership with Amplify, an organization working to grow Louisville’s entrepreneurship ecosystem, with funding from the Kentucky Cabinet for Economic Development.

“We’re thrilled to have Dr. Goldberg join our team, and for the continued growth of the entrepreneurs-in-residence program in partnership with Amplify,” said Will��Metcalf,��a UofL associate vice president for research and innovation.��“Our EIRs bring incredible experience and connection to UofL – Dr. Goldberg is the perfect example of that, joining us through a connection with another EIR, Alice Shade. His experience in health and medical innovation is a powerful addition to our already strong team and will undoubtedly drive innovation forward.”

Both will serve as entrepreneurs in residence, or EIRs, through the . In this role, they will work with inventors to connect UofL technologies to industry and startups.

Dawson has extensive experience in healthcare and biotech, both as an executive and entrepreneur. He founded Renew Recovery, a drug addiction treatment facility offering structured intensive outpatient treatment for those suffering from substance abuse disorders. The company was acquired by Brightview Health in 2020.

“UofL has a long history of developing and launching health-related technologies and companies,” Dawson said.��“I’m looking forward to helping further that momentum and innovations that can improve the way we prevent, diagnose and treat disease.”

Bailey is a UofL alum who cut his teeth as a tech and manufacturing founder, launching companies like Revio, a powersports electronics, and Lucid Customs, a producer of induction heating equipment. Lucid was acquired by Dynavap, LLC in 2020.��

“As a proud Cardinal, I’m excited to work with researchers and the Office of Research and Innovation to get this cutting-edge tech to market,” he said.

Dawson and Bailey join a class of EIRs that currently includes seasoned founders Alice Shade (healthcare), Tendai Charasika (software) and Josh Nickols (biotech). Nickols joined as part of the first round of EIRs , followed by Shade��in 2020 and Charasika in 2021.

The EIR program is led by the Office of Research and Innovation’s UofL New Ventures team, which focuses on launching startups around research-born tech. The EIR program is in partnership with Amplify, an organization working to grow Louisville’s entrepreneurship ecosystem, with funding from the Kentucky Cabinet for Economic Development.

“We’re very excited to have Bill and Chris join us as EIRs, and to benefit from their knowledge and experience as founders,” said Will Metcalf, a UofL associate vice president for research and innovation. “This is such a strong team with broad expertise, and I can’t wait to work with them to further UofL-born innovations and startups.”